A financial innovation that could cure diseases

BioBonds would help fuel a key stage of medical research that often struggles to get funding.

A podcast from MarketWatch in which Karen and Foundation Fighting Blindness CEO Ben Yerxa are interviewed on the BioBonds legislation.  They explain how the greatest problem facing medical research is not the science but funding, going on to show how BioBonds would bring much needed capital into the clinical research arena at low risk to investors.